2025
Geometry-directed cyclisation within the transfer-dominated branching radical telomerisation of dimethacrylates.
C Smith, OB Penrhyn-Lowe, S Mckeating, S Wright, AB Dwyer, SP Rannard
Polym. Chem., 2025,16, 1486-1492
Novel hyperbranched polymers from Transfer-dominated Branching Radical Telomerisation (TBRT) of diacrylate taxogens
S Mckeating, C Smith, O Penrhyn-Lowe,
S Flynn, S Wright, P Chambon, A Dwyer,
Polym. Chem., 2025,16, 1131-1138
Development of solid drug nanoparticle dispersions for pulmonary delivery of niclosamide and nitazoxanide via vibrating mesh nebulisation
C Unsworth, AB Dwyer, AC Savage,
JJ Hobson, J Massam, TO McDonald,
P Curley, A Owen, A O’Sullivan,
RSC Pharm., 2025,2, 517-526
Structure–Activity Relationship Studies of Emtricitabine Prodrugs toward Long-Acting Antiretroviral Formulations
A Al-Khouja, S Henriquez JJ Hobson J A White, C Flexner, A Owen, SP Rannard CL Freel Meyers
ACS Omega 2025, 10, 27, 29721–29731
Nanomedicine strategies to improve therapeutic agents for the prevention and treatment of preterm birth and future directions
J Taylor, A Sharp, SP Rannard, S Arrowsmith and T O McDonald
Nanoscale Adv., 2023,5, 1870-1889
The synthesis of indomethacin prodrugs for the formation of nanosuspensions by emulsion templated freeze drying
J Taylor, A Sharp, SP Rannard, S Arrowsmith and T O McDonald
RSC Adv., 2025, 15, 43830-43843
Patient and provider preferences for long-acting TB preventive therapy.
M Vermeulen, KK Scarsi, R Furl, H Sayles, MJ Anderson, S Valawalkar, A Kadam, SR Cox, V Mave, M Barthwal, C Schutz, A Ward , J Dountio Ofimboudem, G Meintjes, S Rannard, A Owen, S Swindells
IJTLD Open. 2025, 12, 2, 276-283
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income Countries
R Furl, K K Scarsi, H Sayles, M Anderson, J Dountio Ofimboudem, E D Weld, I Waked, A Gomaa, A Al-Khatib, F M Elshobary, H Desalegn, H Fisseha, S Solomon, S Mehta, A Owen, S Rannard, D L Thomas, S Swindells
J Viral Hepatitis 2025, 32, e14031.
© 2018









